Phase II Vanguards

Phase II Vanguards is an interactive data visualization tool providing a comprehensive oversight of the dynamic world of Phase II clinical trials spearheaded by small pharma companies and research innovators.

Explore a wealth of information from geographical distribution, disease focus, drug development progress, to study statuses, and unlock valuable insights into the pioneering forces driving breakthroughs in healthcare.

Number of Investigational New Drugs Investigated by a Vanguard Company

Selected year

Number of Active Clinical Trials Run by Vanguard Companies, Categorized by Primary Disease

Selected company

Number of Active Clinical Trials Run by Vanguard Companies by Status and Primary Disease

Selected year

Geographical distribution of vanguard companies' phase II study sites (2021 - 2023)

Selected company

Experience the power of data visualization with eyesON interactive visualizers.

Explore more and discover insights you never knew existed.